Screen LibraryPlant-derived anticancer drugs in the omics era : biosynthesis, functions, and applications /
"The current anti-cancer synthetic medicines are inefficient and unsafe. The plants-based lead molecules such as taxol, camptothecin, podophyllotoxins, vinblastine, vincristine, homoharringtonine and numerous other anticancer compounds from Nature's arsenal are potentially safe and powerfu...
Saved in:
| Group Author: | ; |
|---|---|
| Published: |
Apple Academic Press,
|
| Publisher Address: | Palm Bay, FL : |
| Publication Dates: | 2024. |
| Literature type: | Book |
| Language: | English |
| Edition: | First edition. |
| Subjects: | |
| Summary: |
"The current anti-cancer synthetic medicines are inefficient and unsafe. The plants-based lead molecules such as taxol, camptothecin, podophyllotoxins, vinblastine, vincristine, homoharringtonine and numerous other anticancer compounds from Nature's arsenal are potentially safe and powerful alternative means that effectively fight against cancer. The volume looks at a variety of medicinal plants and approaches that have beneficial results against cancer. Topics include Unani approaches of anticancer plants, genetic engineering and CRISPR/CAS-mediated editing to enhance anticancer potential, computational approaches used in anticancer plants, and more. The volume also examines the metabolomics of plants that give them anti-cancer properties. This volume, Plant-Derived Anticancer Drugs in the OMICS Era: Biosynthesis, Function, and Applications, will be valuable to cancer researchers and drug developers among others"-- |
| Carrier Form: | xx, 302 pages : illustrations (some color), forms ; 24 cm |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9781774912652 1774912651 |
| Index Number: | RS431 |
| CLC: |
R730.5 R979.1 |
| Call Number: | R979.1/P713 |